Abstract
We had reported advantage of continuous hyperthermic peritoneal perfusion (CHPP) for the prevention of peritoneal recurrence after surgery for gastric cancer in a historical control study. We performed CHPP (CHPP group, n=22) or continuous normothermic peritoneal perfusion (CNPP group, n=18) combined with cisplatin and mitomycin C for the prevention of peritoneal recurrence. The survival curve of the CHPP group was significantly better than of the CNPP group in log-rank test (p<0.01). This fact showed that not only intraperitoneal perfusion combined with chemotherapy (CNPP) but also intraperitoneal hyperthermia(CHPP) are effective procedures for prevention of peritoneal recurrence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
